<--- Back to Details
First PageDocument Content
Health / AL amyloidosis / Amyloid / Transthyretin-related hereditary amyloidosis / AA amyloidosis / Transthyretin / Light chain deposition disease / Multiple myeloma / Serum amyloid P component / Biology / Anatomy / Amyloidosis
Health
AL amyloidosis
Amyloid
Transthyretin-related hereditary amyloidosis
AA amyloidosis
Transthyretin
Light chain deposition disease
Multiple myeloma
Serum amyloid P component
Biology
Anatomy
Amyloidosis

AMYLOID Compiled by Joel Buxbaum, MD Updated April, 2002 by Martha Skinner, MD and Andra Showalter, MD Updated April, 2003 by Jonathan Kay, MD and David Wu, MD Amyloid Pathogenesis - General 1. Sipe JD. Amyloidosis. Ann

Add to Reading List

Source URL: www.rheumatology.org

Download Document from Source Website

File Size: 68,95 KB

Share Document on Facebook

Similar Documents

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis M. Brett, M. R. Persey, M. M. Reilly, T. Revesz, D. R. Booth, S. E. Booth, P. N. Hawkins, M. B. Pepys and J. A. Morgan-Hughes

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis M. Brett, M. R. Persey, M. M. Reilly, T. Revesz, D. R. Booth, S. E. Booth, P. N. Hawkins, M. B. Pepys and J. A. Morgan-Hughes

DocID: 1uD9w - View Document

1045  LETTER TO THE EDITOR Bone scintigraphy for early detection of transthyretin cardiac amyloidosis Asad Ikram Cardiac amyloidosis (CA) is an underdiagnosed condition

1045 LETTER TO THE EDITOR Bone scintigraphy for early detection of transthyretin cardiac amyloidosis Asad Ikram Cardiac amyloidosis (CA) is an underdiagnosed condition

DocID: 1qZ5a - View Document

Theranostics 2016, Vol. 6, Issue 11  Ivyspring International Publisher  Research Paper

Theranostics 2016, Vol. 6, Issue 11 Ivyspring International Publisher Research Paper

DocID: 1p2ul - View Document

Phase I First-in-Human Trial of ALN-TTRsc, A Novel RNA Interference Therapeutic for the Treatment of Familial Amyloidotic Cardiomyopathy (FAC) Tracy Zimmermann,1 Verena Karsten,1 Jamie Harrop,1 Amy Chan,1 Joseph Chiesa,2

Phase I First-in-Human Trial of ALN-TTRsc, A Novel RNA Interference Therapeutic for the Treatment of Familial Amyloidotic Cardiomyopathy (FAC) Tracy Zimmermann,1 Verena Karsten,1 Jamie Harrop,1 Amy Chan,1 Joseph Chiesa,2

DocID: 1ftvI - View Document

Jiao et al. Italian Journal of Pediatrics 2011, 37:11 http://www.ijponline.net/contentITALIAN JOURNAL OF PEDIATRICS

Jiao et al. Italian Journal of Pediatrics 2011, 37:11 http://www.ijponline.net/contentITALIAN JOURNAL OF PEDIATRICS

DocID: 1aG7a - View Document